The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,344.00
Ask: 12,346.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,268.00
High: 12,388.00
Low: 12,256.00
Prev. Close: 12,264.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

Thu, 08th Feb 2024 17:00

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

The FTSE 100 index fell 33.27 points, 0.4%, at 7,595.48. The FTSE 250 closed well off session highs, slipping 1.81 points to 19,102.72. The AIM All-Share closed down 0.36 of a point to 751.10.

The Cboe UK 100 ended down 0.5% at 759.41, the Cboe UK 250 edged up 0.1% at 16,537.00, and the Cboe Small Companies closed down 0.4% at 14,580.46.

In European equities on Thursday, the CAC 40 in Paris closed up 0.7%, while the DAX 40 in Frankfurt ended 0.3% higher.

In New York, the Dow Jones Industrial Average was down 0.3%, the S&P 500 was 0.1% lower so still off 5,000 points, while the Nasdaq Composite added 0.2%.

"It seems inevitable that this key [5,000 points] psychological level could be coming. The question now is what happens after this level is potentially breached? There is a bit of market nervousness around the 5,000 level and the index is fluctuating ahead of this level," XTB analyst Kathleen Brooks commented.

Brooks noted that the S&P 500 has outpaced European peers so far this year so it could be hurt by "fatigue" if it does breach the 5,000 mark, the analyst predicted.

Focus was also on words from US monetary policymakers.

Richmond Fed President Tom Barkin said he was "very supportive of being patient" on announcing the first reduction. Fed Governor Adriana Kugler added that she wanted to wait until more data was available before moving.

The pound was quoted at USD1.2609 late on Thursday afternoon in London, lower compared to USD1.2623 at the equities close on Wednesday. The euro stood at USD1.0763, flat against USD1.0765. Against the yen, the dollar was trading at JPY149.39, up compared to JPY148.01.

In London, it was a busy day of earnings and corporate updates.

DS Smith topped the FTSE 100 index, rising by 9.8%, after announcing it received a preliminary takeover approach from peer Mondi. Mondi shares fell 0.2%.

Mondi talked up the idea of a possible bid for its packaging peer, but said an acquisition would need to fit its capital allocation policy.

Mondi said it is in the early stages of considering a bid for DS Smith. It believes a tie-up would be an "exciting opportunity to create an industry leader in European paper-based sustainable packaging solutions".

The possible merger would create a company worth more than GBP10 billion.

Mondi added: "Mondi's strategy is to deliver value accretive growth and, as noted above, adopts a disciplined approach to acquisitions and investment within its capital allocation framework. Any transaction with DS Smith would be assessed against this framework.

"Mondi remains committed to maintaining a strong and stable financial position supported by a solid investment grade credit rating and a dividend policy aimed at offering shareholders long-term dividend growth within the context of its stated cover policy."

British American Tobacco shares rose 7.1% as it reported weaker annual results, though there was still plenty for investors to cheer. It hinted at a possible sale of its stake in Indian holding ITC, and also announced progress in its New Categories offering.

The London-based maker of cigarettes and vapes said it regularly reviews its stake in ITC, "a significant shareholding which offers us the opportunity to release and reallocate some capital".

"We have been actively working for some time on completing the regulatory process required to give us the flexibility to monetise some of our shareholding," BAT continued.

ITC is a Kolkata, India-based company. It is India's biggest cigarette maker but has diversified into other businesses including luxury hotels. BAT owns a 29% stake valued at around GBP14 billion.

In addition, BAT said the company has hit profitability with its 'new categories' products, sooner than forecast.

The comments came as BAT reported results for 2023 which showed revenue fell 1.3% to GBP27.28 billion from GBP27.66 billion in 2022. Revenue was shy of Vuma consensus of GBP27.60 billion

The company swung to a pretax loss of GBP17.06 billion from a profit of GBP9.32 billion a year prior.

A buyback helped support Unilever shares. The consumer goods company added 3.2%.

The London-based maker of food & drink, cleaning, toiletry, and personal care products said pretax profit fell 9.7% to EUR9.34 billion in 2023 from EUR10.34 billion in 2022, as revenue slipped 0.8% to EUR59.60 billion from EUR60.07 billion. Revenue fell short of company-compiled consensus of EUR60.04 billion.

The company also announced a new share buyback programme worth up to EUR1.5 billion, set to begin in the second quarter and be completed within 2024.

"A return to volume growth and improved sales margins on a group basis would suggest Unilever is getting back in the groove. However, the journey still has some way to go as there are pockets of weakness which it needs to resolve," AJ Bell analyst Russ Mould commented.

Sliding, however, AstraZeneca gave back 6.4%. The Cambridge, England-based pharmaceutical company said that in the fourth quarter ending December, revenue increased to USD12.02 billion from USD11.21 billion the year before, up 7% on an actual basis and 8% at constant currency.

Revenue was shy of the USD12.09 billion that was expected, according to LSEG-cited consensus.

Pretax profit climbed 15% or 18% at constant currency to USD897 million from USD778 million the year prior, while reported earnings per share rose 7% to USD0.62 from USD0.58.

Elsewhere in London, Digital 9 shares tumbled 24%.

Back in November, the investor had announced the sale of its stake in the Verne Group for up to USD575 million. The disposal of the data group to funds managed by Ardian France SA comprises USD440 million in cash, split between USD415 million payable on closure of the deal and deferred consideration of USD25 million.

On Thursday, Digital 9 said the Icelandic antitrust authority, the body responsible for providing the Icelandic regulatory approval, has decided to open a phase 2 investigation into the Verne transaction.

"Under the relevant applicable law, the period for the Phase II investigation is up to 90 working days which can be extended to 125 working days. The Icelandic anti-trust authority is not obliged to use the full period to conclude its review," Digital 9 said.

Brent oil was quoted at USD81.02 a barrel late Thursday in London, up from USD78.98 late Wednesday. Gold was quoted at USD2,029.31 an ounce, lower against USD2,039.13.

On Friday, financial markets in Shanghai are closed for the Chinese New Year. Markets in Hong Kong will have an abbreviated session. There is a German inflation reading at 0700 GMT, and Irish industrial production at 1100 GMT.

The local corporate calendar has a trading statement from housebuilder Bellway.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.